View in EDS

RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT.

Saved in:
Bibliographic Details
Title: RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT.
Authors: DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Choe H; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Efebera YA; Division of Hematology, Department of Blood and Marrow Transplant, OhioHealth, The Ohio State University, Columbus, OH., Saad A; Division of Acute Leukemia, College of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia., Farhan S; Division of Hematology Oncology, Department of Internal Medicine, Henry Ford Health, Detroit, MI., Lekakis L; Division of Transplantation and Cellular Therapy, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL., Yared JA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Schiller G; Division of Hematology and Oncology, David Geffen School of Medicine at University of California, Los Angeles, CA., Mapara MY; Division of Hematology/Oncology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY., Assal A; Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY., Gooley T; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Bui JD; Department of Pathology, University of California San Diego, La Jolla, CA., Lee D; Department of Clinical Development, REGiMMUNE Corporation, Tokyo, Japan., Lane H; Department of Clinical Development, REGiMMUNE Corporation, Tokyo, Japan., Chen YB; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA.
Source: Blood [Blood] 2025 Oct 23; Vol. 146 (17), pp. 2037-2046.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40680268
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22DeFilipp+Z%22">DeFilipp Z</searchLink>; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Choe+H%22">Choe H</searchLink>; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Efebera+YA%22">Efebera YA</searchLink>; Division of Hematology, Department of Blood and Marrow Transplant, OhioHealth, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Saad+A%22">Saad A</searchLink>; Division of Acute Leukemia, College of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Farhan+S%22">Farhan S</searchLink>; Division of Hematology Oncology, Department of Internal Medicine, Henry Ford Health, Detroit, MI.<br /><searchLink fieldCode="AU" term="%22Lekakis+L%22">Lekakis L</searchLink>; Division of Transplantation and Cellular Therapy, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Yared+JA%22">Yared JA</searchLink>; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Schiller+G%22">Schiller G</searchLink>; Division of Hematology and Oncology, David Geffen School of Medicine at University of California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Mapara+MY%22">Mapara MY</searchLink>; Division of Hematology/Oncology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.<br /><searchLink fieldCode="AU" term="%22Assal+A%22">Assal A</searchLink>; Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY.<br /><searchLink fieldCode="AU" term="%22Gooley+T%22">Gooley T</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Bui+JD%22">Bui JD</searchLink>; Department of Pathology, University of California San Diego, La Jolla, CA.<br /><searchLink fieldCode="AU" term="%22Lee+D%22">Lee D</searchLink>; Department of Clinical Development, REGiMMUNE Corporation, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Lane+H%22">Lane H</searchLink>; Department of Clinical Development, REGiMMUNE Corporation, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Chen+YB%22">Chen YB</searchLink>; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2025 Oct 23; Vol. 146 (17), pp. 2037-2046.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40680268
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2025029584
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2037
    Titles:
      – TitleFull: RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: DeFilipp Z
      – PersonEntity:
          Name:
            NameFull: Choe H
      – PersonEntity:
          Name:
            NameFull: Efebera YA
      – PersonEntity:
          Name:
            NameFull: Saad A
      – PersonEntity:
          Name:
            NameFull: Farhan S
      – PersonEntity:
          Name:
            NameFull: Lekakis L
      – PersonEntity:
          Name:
            NameFull: Yared JA
      – PersonEntity:
          Name:
            NameFull: Schiller G
      – PersonEntity:
          Name:
            NameFull: Mapara MY
      – PersonEntity:
          Name:
            NameFull: Assal A
      – PersonEntity:
          Name:
            NameFull: Gooley T
      – PersonEntity:
          Name:
            NameFull: Bui JD
      – PersonEntity:
          Name:
            NameFull: Lee D
      – PersonEntity:
          Name:
            NameFull: Lane H
      – PersonEntity:
          Name:
            NameFull: Chen YB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 10
              Text: 2025 Oct 23
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 146
            – Type: issue
              Value: 17
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1